Copyright Reports & Markets. All rights reserved.

Global HIV Diagnosis Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global HIV Diagnosis Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Antibody Tests
      • 1.4.3 Viral Load Tests
      • 1.4.4 CD4 Tests
      • 1.4.5 Tests for Early Infant Diagnosis
      • 1.4.6 Tests for Viral Identification
    • 1.5 Market by Application
      • 1.5.1 Global HIV Diagnosis Market Share by Application (2014-2025)
      • 1.5.2 Diagnostic Laboratories
      • 1.5.3 Hospitals
      • 1.5.4 Blood Banks
      • 1.5.5 Home Care Settings
      • 1.5.6 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 HIV Diagnosis Market Size
    • 2.2 HIV Diagnosis Growth Trends by Regions
      • 2.2.1 HIV Diagnosis Market Size by Regions (2014-2025)
      • 2.2.2 HIV Diagnosis Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 HIV Diagnosis Market Size by Manufacturers
      • 3.1.1 Global HIV Diagnosis Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global HIV Diagnosis Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global HIV Diagnosis Market Concentration Ratio (CR5 and HHI)
    • 3.2 HIV Diagnosis Key Players Head office and Area Served
    • 3.3 Key Players HIV Diagnosis Product/Solution/Service
    • 3.4 Date of Enter into HIV Diagnosis Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global HIV Diagnosis Market Size by Type (2014-2019)
    • 4.2 Global HIV Diagnosis Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States HIV Diagnosis Market Size (2014-2019)
    • 5.2 HIV Diagnosis Key Players in United States
    • 5.3 United States HIV Diagnosis Market Size by Type
    • 5.4 United States HIV Diagnosis Market Size by Application

    6 Europe

    • 6.1 Europe HIV Diagnosis Market Size (2014-2019)
    • 6.2 HIV Diagnosis Key Players in Europe
    • 6.3 Europe HIV Diagnosis Market Size by Type
    • 6.4 Europe HIV Diagnosis Market Size by Application

    7 China

    • 7.1 China HIV Diagnosis Market Size (2014-2019)
    • 7.2 HIV Diagnosis Key Players in China
    • 7.3 China HIV Diagnosis Market Size by Type
    • 7.4 China HIV Diagnosis Market Size by Application

    8 Japan

    • 8.1 Japan HIV Diagnosis Market Size (2014-2019)
    • 8.2 HIV Diagnosis Key Players in Japan
    • 8.3 Japan HIV Diagnosis Market Size by Type
    • 8.4 Japan HIV Diagnosis Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia HIV Diagnosis Market Size (2014-2019)
    • 9.2 HIV Diagnosis Key Players in Southeast Asia
    • 9.3 Southeast Asia HIV Diagnosis Market Size by Type
    • 9.4 Southeast Asia HIV Diagnosis Market Size by Application

    10 India

    • 10.1 India HIV Diagnosis Market Size (2014-2019)
    • 10.2 HIV Diagnosis Key Players in India
    • 10.3 India HIV Diagnosis Market Size by Type
    • 10.4 India HIV Diagnosis Market Size by Application

    11 Central & South America

    • 11.1 Central & South America HIV Diagnosis Market Size (2014-2019)
    • 11.2 HIV Diagnosis Key Players in Central & South America
    • 11.3 Central & South America HIV Diagnosis Market Size by Type
    • 11.4 Central & South America HIV Diagnosis Market Size by Application

    12 International Players Profiles

    • 12.1 Siemens Healthineers
      • 12.1.1 Siemens Healthineers Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 HIV Diagnosis Introduction
      • 12.1.4 Siemens Healthineers Revenue in HIV Diagnosis Business (2014-2019)
      • 12.1.5 Siemens Healthineers Recent Development
    • 12.2 Roche Diagnostics
      • 12.2.1 Roche Diagnostics Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 HIV Diagnosis Introduction
      • 12.2.4 Roche Diagnostics Revenue in HIV Diagnosis Business (2014-2019)
      • 12.2.5 Roche Diagnostics Recent Development
    • 12.3 Abbott Laboratories
      • 12.3.1 Abbott Laboratories Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 HIV Diagnosis Introduction
      • 12.3.4 Abbott Laboratories Revenue in HIV Diagnosis Business (2014-2019)
      • 12.3.5 Abbott Laboratories Recent Development
    • 12.4 Beckman Coulter
      • 12.4.1 Beckman Coulter Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 HIV Diagnosis Introduction
      • 12.4.4 Beckman Coulter Revenue in HIV Diagnosis Business (2014-2019)
      • 12.4.5 Beckman Coulter Recent Development
    • 12.5 Thermo Fisher
      • 12.5.1 Thermo Fisher Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 HIV Diagnosis Introduction
      • 12.5.4 Thermo Fisher Revenue in HIV Diagnosis Business (2014-2019)
      • 12.5.5 Thermo Fisher Recent Development
    • 12.6 Merck
      • 12.6.1 Merck Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 HIV Diagnosis Introduction
      • 12.6.4 Merck Revenue in HIV Diagnosis Business (2014-2019)
      • 12.6.5 Merck Recent Development
    • 12.7 Becton, Dickinson
      • 12.7.1 Becton, Dickinson Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 HIV Diagnosis Introduction
      • 12.7.4 Becton, Dickinson Revenue in HIV Diagnosis Business (2014-2019)
      • 12.7.5 Becton, Dickinson Recent Development
    • 12.8 Hologic
      • 12.8.1 Hologic Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 HIV Diagnosis Introduction
      • 12.8.4 Hologic Revenue in HIV Diagnosis Business (2014-2019)
      • 12.8.5 Hologic Recent Development
    • 12.9 Alere
      • 12.9.1 Alere Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 HIV Diagnosis Introduction
      • 12.9.4 Alere Revenue in HIV Diagnosis Business (2014-2019)
      • 12.9.5 Alere Recent Development
    • 12.10 Bio-Rad Laboratories
      • 12.10.1 Bio-Rad Laboratories Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 HIV Diagnosis Introduction
      • 12.10.4 Bio-Rad Laboratories Revenue in HIV Diagnosis Business (2014-2019)
      • 12.10.5 Bio-Rad Laboratories Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      HIV Diagnosis are used to detect the presence of the human immunodeficiency virus (HIV), the virus that causes acquired immunodeficiency syndrome (AIDS), in serum, saliva, or urine. Such tests may detect antibodies, antigens, or RNA.
      The antibody tests segment is expected to account for the largest share of the market in 2016. This large share can be attributed to high prevalence of HIV/AIDS, increasing awareness about HIV/AIDS, increasing blood donations and advancements, and better offerings from PoC testing.
      The diagnostic laboratories segment is expected to account for the largest share of market in 2018. This large share is mainly due to high investment and technological advancements of diagnostics laboratories and increasing awareness of HIV/AIDS
      In 2018, the global HIV Diagnosis market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global HIV Diagnosis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the HIV Diagnosis development in United States, Europe and China.

      The key players covered in this study
      Siemens Healthineers
      Roche Diagnostics
      Abbott Laboratories
      Beckman Coulter
      Thermo Fisher
      Merck
      Becton, Dickinson
      Hologic
      Alere
      Bio-Rad Laboratories

      Market segment by Type, the product can be split into
      Antibody Tests
      Viral Load Tests
      CD4 Tests
      Tests for Early Infant Diagnosis
      Tests for Viral Identification

      Market segment by Application, split into
      Diagnostic Laboratories
      Hospitals
      Blood Banks
      Home Care Settings
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global HIV Diagnosis status, future forecast, growth opportunity, key market and key players.
      To present the HIV Diagnosis development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of HIV Diagnosis are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now